AVCRF.US Avricore Health Inc

Healthcare Biotechnology USA Stocks
0.0008 USD
Close of Nov 13, 2026
0.0008 0.0787
Market cap
USD 101K
P/E
-
P/B
0.13x
ROE
-217.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is AVCRF.US undervalued?

Graham number

The Graham number of Avricore Health Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Avricore Health Inc fundamental analysis

No fundamental analysis for Avricore Health Inc yet.

Avricore Health Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Avricore Health Inc

Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 an…

Full company profile